SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-20-020362
Filing Date
2020-10-21
Accepted
2020-10-21 06:42:18
Documents
7
Period of Report
2020-10-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp139005_6k.htm 6-K 12606
2 EXHIBIT 99.1 dp139005_ex9901.htm EX-99.1 69277
3 EXHIBIT 99.2 dp139005_ex9902.htm EX-99.2 7140
4 GRAPHIC image_013.jpg GRAPHIC 2219
5 GRAPHIC image_012.jpg GRAPHIC 2322
6 GRAPHIC image_014.jpg GRAPHIC 91659
7 GRAPHIC image_002.jpg GRAPHIC 283147
  Complete submission text file 0000950103-20-020362.txt   612970
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 201249578
SIC: 2834 Pharmaceutical Preparations